Should I buy Barclays stock right now?

Buying Barclays stock depends on your risk tolerance, investment horizon, and market outlook. The analyst consensus shown on this page is a BUY, but you should do your own research before deciding to open a position.

Is Barclays a good stock to buy?

Barclays carries a TipRanks Smart Score of 8 out of 10, aggregating 8 market factors, which indicates the stock is overperforming the market. Whether it suits you depends on your risk tolerance, investment horizon, and market outlook, so do your own research before opening a position.

How do I buy Barclays stock?

To buy Barclays stock (BCS), open and fund an account with a brokerage platform that offers stock trading and investing, such as NAGA. Then search for the ticker BCS, decide how many shares or what amount to invest, and place a market or limit order.

Should I hold Barclays stock?

Holding can suit long-term investors if the company maintains stable growth. The analyst consensus on this page is a BUY, but you should do your own research before making a decision.

What is the sentiment of Barclays stock?

The crowd sentiment score for Barclays, provided by Trading Central, is currently negative, and investor sentiment is also positive.

Will Barclays stock price go up?

Wall Street analysts covering Barclays give an average 12-month price target of $20.61. Analyst targets are estimates only and are not guarantees of future outcomes, so do your own research before opening a position.

How high can Barclays stock price go?

The highest 12-month analyst price target for Barclays on this page is $33.50. Analyst targets are estimates only and do not guarantee future results.

How low can Barclays stock price go?

The lowest 12-month analyst price target for Barclays on this page is $7.72. Analyst targets are estimates only and do not guarantee future results.

What will Barclays stock be worth in one year?

Based on Wall Street analysts’ 12-month projections, the average price target for Barclays is $20.61. This is a consensus estimate, not a guarantee of future value.

Is Barclays stock undervalued or overvalued?

The quantitative Smart Score of 8 indicates Barclays is overperforming the market. There is a risk of overvaluation if the price trades well above the average analyst price target of $20.61 or shows an elevated P/E versus its sector.

Barclays è un buon titolo da acquistare a October 2026

Perché il prezzo del titolo BARCLAYS sta salendo?

BARCLAYS

I rialzisti dicono

Diversified universal banking model
Barclays’ broad universal banking model spreads earnings across consumer finance, deposits, payments, corporate banking, wealth and markets. This diversification can reduce dependence on any single customer group or revenue stream while allowing the bank to deepen relationships and cross-sell services over time.
Improving income, profitability and efficiency
Strong income and profit growth, alongside a lower cost-to-income ratio, indicates improving operating leverage across the franchise. If efficiency savings and broad-based revenue growth persist, Barclays should have greater capacity to support investment, absorb credit costs and sustain returns over the coming quarters.
Strong capital and liquidity position
Barclays’ capital and liquidity metrics provide meaningful financial resilience. A solid CET1 ratio, substantial high-quality liquidity coverage and a conservative loan-to-deposit ratio support the bank’s ability to meet obligations, continue lending and manage market or credit stress without immediate funding strain.

Perché il prezzo del titolo BARCLAYS sta scendendo?

BARCLAYS

I ribassisti dicono

High leverage and inconsistent cash conversion
The sharp leverage increase reduces financial flexibility and makes earnings more sensitive to funding conditions and credit deterioration. Repeated volatility in operating and free cash flow also weakens confidence that reported profitability consistently converts into internally available funding for growth and capital needs.
Elevated credit and regulatory capital pressures
Higher impairments can directly reduce earnings, while future regulatory RWA inflation may require additional capital against existing activities. Together, these pressures could constrain distribution capacity, raise the cost of balance-sheet growth and make returns more dependent on successful risk and capital management.
Persistent cost and margin pressure
Rising compensation and regulatory-related expenses may offset part of Barclays’ revenue growth, particularly while further restructuring actions are being implemented. Cost pressure can delay progress toward the long-term efficiency target and leave profitability more exposed to weaker margins or slower client activity.

BARCLAYS Titolo (BCS.re) Grafico del prezzo, analisi e previsioni

prezzo live di BCS